Familial thrombophilia and idiopathic intracranial hypertension

References

• Smith. Whence Pseudotumour cerebri? J Guth Neuro Ophthalmol. 1985;5:55–56.
   Google Scholar
• De Bruijn S, Stam J, Koopman M, et al. Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users and in carriers of hereditary prothrombotic conditions. The cerebral venous Sinus Thrombosis Study Group. Br Med J. 1998;316:589–592.
   Google Scholar
• Daif A, Awada A, Al-Rajeh S, et al. Cerebral venous thrombosis in adults. A study of 40 cases from Saudi Arabia. Stroke. 1995;26: 1193–1195.
   Google Scholar
• Vandenbroucke J. Cerebral sinus thrombosis and oral contraceptives. Br Med J. 1998;317:483–484.
   PubMedGoogle Scholar
• Confravreux C, Brunet P, Petiot P, et al. Congenital protein C deficiency and sagital sinus thrombosis causing isolated intracranial hypertension. J Neurol Neurosurg Psychiatry. 1994; 57:655–657.
   PubMedGoogle Scholar
• Sussman J, Leach M, Greaves M, et al. Potentially prothrombotic abnormalities of coagulation in benign intracranial hypertension. J Neurol Neurosurg Psychiatry. 1997;62:229–233.
   PubMed Web of Science ®Google Scholar
• Leker R, Steiner I. Anticardolipin antibodies are frequently present in patients with idiopathic intracranial hypertension. Arch Neurol. 1998;55: 817–820.
   PubMedGoogle Scholar
• Backhouse O, Metcalfe T, Goulding P, et al. Factor V Leiden mutation in association with idiopathic intracranial hypertension. Br J OphthalmoL 1998;82(7):844.
   PubMedGoogle Scholar
• Orefice G, De Jonna G, Coppola M, et al. Benign intracranial hypertension: a non-thrombotic complication of the primary antiphospholipid syndrome? Lupus. 1995;4:324–326.
   Google Scholar
• de Ronde H, Bertina M. Laboratory diagnosis of APC-resistance: a critical evaluation of the test and the development of diagnostic criteria. Thromb Haemost. 1994;72(6): 88o-886.
   Google Scholar
• Poort S, Rosendaal F, Reitsma P, et al. A common genetic variation in the 3' untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88(10): 3698–3703.
   PubMed Web of Science ®Google Scholar
• Giuseffi V, Wall M, Siegel P, et al. Symptoms and disease associations in idiopathic intracranial hypertension (Pseudotumour cerebri): a case-control study. Neurology. 1991;41:239–244.
   PubMed Web of Science ®Google Scholar
• Ireland B, Corbett J, Wallace R. The search for causes of Pseudotumour cerebri: a preliminary case-control study. Arch Neurol. 1990;47:315–320.
   PubMed Web of Science ®Google Scholar
• Asherson R, Khamashta M, Ordi-Ros J, et al. The 'primary' antiphospholipid syndrome: major clinical and serological features. Medicine. 1989;68:366–374.
   Google Scholar
• Fields R, Toubbeh H, Searles R, et al. The prevelance of anticardolipin antibodies in a healthy elderly population and its association with antinuclear antibodies. J RheumatoL 1989;16:623–625.
   PubMed Web of Science ®Google Scholar
• Boumpas D, Fessler B, Austin H, et al. Systemic lupus erythematosus: emerging concepts. Part 2. Dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality and pathogenesis. Ann Intern Med. 1995; 123:42–53.
   Google Scholar
• Ames P, Tommasino C, D'Andrea G, et al. Thrombophilic genotypes in subjects with idiopathic antiphospholipid antibodies — prevalence and significance. Thromb Haemost. 1998;79:46–49.
   Google Scholar
• Green L, Vinker S, Amital H, et al. Pseudotumour cerebri in systemic lupus erythematosus. Semin Arthritis Rheum. 1995;25:103–108.
   PubMedGoogle Scholar
• Angelini L, Zibordi F, Zorzi G, et al. Neurological disorders, other than stroke, associated with antiphospholipid antibodies in childhood. Neuropediatrics. 1996;27:149–153.
   PubMedGoogle Scholar
• Santoro S. Antiphospholipid antibodies and thrombotic predisposition: underlying pathogenic mechanisms. Blood. 1994;8:2389–2391.
   Google Scholar
• Hill M, et al. Characterisation and specificity of antiendothelial cell membrane antibodies and their relationship to thrombosis in the primary antiphospholipid syndrome. Lupus. 1994;3:333 (abs No.83).
   Google Scholar
• Khamashta M, Cuadrado M, Mujic F, et al. The management of thrombosis in the antiphospholipid syndrome. N Engl J Med. 1995; 332:993–997.
   PubMed Web of Science ®Google Scholar
• Backhouse O. Idiopathic intracranial hypertension and anticardolipin antibodies. J Neurol Neurosurg Psychiatry. 200 I ;70:420-42 I .
   Google Scholar
• Gardner K, Cox T, Digre K. Idiopathic intracranial hypertension associated with tetracycline use in fraternal twin. Neurology. 1995;45:6–m
   Google Scholar
• Chiu A, Chuenkougkaew W, Cornblath W, et al. Minocycline treatment and Pseudotumour cerebri syndrome. Am J OphthalmoL 1998;126:116–121.
   PubMed Web of Science ®Google Scholar
• Edman C, Alman E, Porter J. Identification of the estrogen product of extraglandular aromatization of plasma androstenedione. Am J Obstet GynecoL 1978;130:439–447.
   PubMedGoogle Scholar
• Daly L, Bonnar J. Comparative studies of 3og ethinyl estradiol combined with gestodene and desogestrel on blood coagulation, fibrinolysis, and platelets. Am J Obstet GynecoL 1990;163:430–437.
   PubMed Web of Science ®Google Scholar
• Kluft C. Renewed interest in haemostasis changes induced by oral contraceptives (Ocs). Thromb Haemost. 2000;84:1–3.
   PubMedGoogle Scholar
• Wall M. Idiopathic intracranial hypertension. Neurol Clin. 1991:9:73–95.
   PubMedGoogle Scholar